6 years ago

Emergex Vaccines Raises €9.9 Million for Infectious Disease Vaccines

  • Emergex Vaccines, a UK-based biotech startup, has secured over €9.9 million in a Series A round to progress its vaccines for Zika, Dengue Fever, and Ebola.

      • ProblemHealthcare

      "A way to produce vaccines quickly, easily, and at a lower cost to increase access to a larger number of people around the world"

      Solution

      "Emergex's set-point vaccines deliver experimentally-derived pathogen peptide data via quantum-sized nanoclusters to prime the immune system to recognise subsequent infections, mimicking natural infection and preventing severe manifestation of the disease, and can be produced quickly, administered easily and sold at a fraction of current prices"

      Covered on